WALTERS GROUP - 31 Dec 2025 Form 4 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
08 Jan 2026, 16:57:05 UTC
Prior SEC filing
08 Jan 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ The Walters Group, By: /s/ Susan B. Walters, Name: Susan B. Walters, Title: General Partner

Key filing fact

WALTERS GROUP filed Form 4 for Zentalis Pharmaceuticals, Inc. (ZNTL) on 08 Jan 2026.

Key facts

  • This page summarizes WALTERS GROUP's Form 4 filing for Zentalis Pharmaceuticals, Inc. (ZNTL).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 08 Jan 2026, 16:57.

Change

  • Previous filing in this sequence was filed on 08 Jan 2026.
  • Current net transaction value: +$7,751,968.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (3)

CIK 0001177523 Primary reporting owner

WALTERS GROUP

Relationship
10%+ Owner
Address
8975 S. PECOS ROAD, UNIT 6A, HENDERSON
Signature
/s/ The Walters Group, By: /s/ Susan B. Walters, Name: Susan B. Walters, Title: General Partner
Signature date
08 Jan 2026
CIK 0001689655

WALTERS WILLIAM THURMAN

Relationship
10%+ Owner
Address
8975 S. PECOS ROAD, UNIT 6A, HENDERSON
Signature
/s/ William T. Walters
Signature date
08 Jan 2026
CIK 0001689761

WALTERS SUSAN BERKLEY

Relationship
10%+ Owner
Address
8975 S. PECOS ROAD, UNIT 6A, HENDERSON
Signature
/s/ Susan B. Walters
Signature date
08 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ZNTL transaction

Common Stock

Purchase

Transaction value
$7,751,968
Shares
+6,459,973
Change %
+92%
Price
$1.20
Shares after
13,509,973
Date
31 Dec 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares of common stock reported herein (the "Shares") are held directly by The Walters Group (the "TWG"). William T. Walters may be deemed to share voting and dispositive power with respect to the Shares. Susan B. Walters is the general partner and majority member of TWG and may be deemed to share voting and dispositive power with respect to the Shares. Each Reporting Person disclaims Section 16 beneficial ownership of the Shares reported herein except to the extent of its pecuniary interest therein, if any, and the inclusion of these Shares in this report shall not be deemed an admission of beneficial ownership of any of the reported Shares for purposes of Section 16 or any other purpose.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .